The global Plasma Albumin market size is predicted to grow from US$ 6098 million in 2025 to US$ 9433 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The plasma albumin market is primarily driven by the increasing demand for albumin in various medical applications. Albumin, a crucial protein found in blood plasma, plays a vital role in maintaining osmotic pressure, transporting nutrients, and regulating pH levels. As a result, it finds extensive use in therapeutic treatments for conditions like hypovolemia, burns, liver cirrhosis, and septic shock. Additionally, the rising prevalence of chronic diseases and surgical procedures further fuels the demand for albumin as a vital component in various medical products and therapies.However, the market also faces challenges, such as the limited availability of human plasma-derived albumin and the strict regulatory guidelines for its collection and purification. Ensuring a stable and adequate supply of albumin can be challenging, especially during times of high demand or unforeseen events. Moreover, the development of alternative albumin sources, such as recombinant human albumin, presents both opportunities and challenges for the market. Overcoming these obstacles through advanced production methods, research, and collaboration within the healthcare industry will be essential in meeting the growing demand and maintaining a sustainable plasma albumin market.

Infinity Market Research newest research report, the Plasma Albumin Industry Forecast looks at past sales and reviews total world Plasma Albumin sales in 2024, providing a comprehensive analysis by region and market sector of projected Plasma Albumin sales for 2025 through 2031. With Plasma Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma Albumin industry.

This Insight Report provides a comprehensive analysis of the global Plasma Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasma Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Plasma Albumin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma Albumin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma Albumin.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Albumin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    20-25% Concentrations
    5% Concentrations

Segmentation by Application:

    Therapeutics
    Excipient
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Grifols
    CSL
    Takeda
    Octapharma
    CBPO
    Hualan Bio
    Kedrion
    Shanghai RAAS
    LFB Group
    Biotest
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio

Key Questions Addressed in this Report

What is the 10-year outlook for the global Plasma Albumin market?
What factors are driving Plasma Albumin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Albumin market opportunities vary by end market size?
How does Plasma Albumin break out by Type, by Application?